Resumen de acción ABBOTINDIA
Abbott India Limited opera como empresa farmacéutica en la India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 6/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en ABBOTINDIA a partir de nuestros controles de riesgos.
Competidores de Abbott India Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹26,065.20 |
| 52 Week High | ₹29,638.95 |
| 52 Week Low | ₹20,605.05 |
| Beta | 0.057 |
| 1 Month Change | -7.87% |
| 3 Month Change | 0.77% |
| 1 Year Change | 15.45% |
| 3 Year Change | 72.52% |
| 5 Year Change | 241.16% |
| Change since IPO | 3,298.33% |
Noticias y actualizaciones recientes
Recent updates
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23
Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?
Oct 25Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?
Oct 04Why Abbott India Limited (NSE:ABBOTINDIA) Should Be In Your Dividend Portfolio
Sep 13Abbott India Limited (NSE:ABBOTINDIA) Looks Interesting, And It's About To Pay A Dividend
Aug 23Is Abbott India's (NSE:ABBOTINDIA) 295% Share Price Increase Well Justified?
Aug 17Earnings Tell The Story For Abbott India Limited (NSE:ABBOTINDIA)
Jul 27What You Need To Know About Abbott India Limited's (NSE:ABBOTINDIA) Investor Composition
Jul 06Rentabilidad de los accionistas
| ABBOTINDIA | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | -3.5% | -2.5% | -2.5% |
| 1Y | 15.4% | 55.2% | 44.5% |
Rentabilidad vs. Industria: ABBOTINDIA obtuvo unos resultados inferiores a los del sector Indian Pharmaceuticals , que el año pasado arrojó un rendimiento del 65.4%.
Rentabilidad vs. Mercado: ABBOTINDIA obtuvo unos resultados inferiores a los del mercado Indian, que fue del 45.9% el año pasado.
Volatilidad de los precios
| ABBOTINDIA volatility | |
|---|---|
| ABBOTINDIA Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Precio estable de las acciones: ABBOTINDIA no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ABBOTINDIA (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1910 | 3,700 | n/a | www.abbott.co.in |
Abbott India Limited opera como empresa farmacéutica en la India. Ofrece productos farmacéuticos para diversas áreas terapéuticas, como salud de la mujer, gastroenterología, metabolismo, sistema nervioso central y vacunas, así como productos multiespecialidad para insomnio, vitamina D, parto prematuro y tratamiento del dolor; y antiinfecciosos, cardiodiabéticos, hormonas, respiratorios, hepáticos, cuidado del consumidor y gastro. La empresa se fundó en 1910 y tiene su sede en Bombay (India).
Resumen de fundamentos de Abbott India Limited
| Estadísticas fundamentales de ABBOTINDIA | |
|---|---|
| Capitalización bursátil | ₹553.66b |
| Beneficios(TTM) | ₹11.46b |
| Ingresos (TTM) | ₹57.53b |
48.3x
Ratio precio-beneficio (PE)9.6x
Ratio precio-ventas (PS)¿Está ABBOTINDIA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ABBOTINDIA | |
|---|---|
| Ingresos | ₹57.53b |
| Coste de los ingresos | ₹31.86b |
| Beneficio bruto | ₹25.68b |
| Otros gastos | ₹14.22b |
| Beneficios | ₹11.46b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 539.11 |
| Margen bruto | 44.63% |
| Margen de beneficio neto | 19.91% |
| Ratio deuda/patrimonio | 2.9% |
¿Cómo se ha desempeñado ABBOTINDIA a largo plazo?
Ver rendimiento histórico y comparativa